Search Results
You are looking at 1 - 4 of 4 items for
- Author: Tânia Maria Ortiga-Carvalho x
- Refine by access: All content x
Search for other papers by Flavia F Bloise in
Google Scholar
PubMed
Search for other papers by Aline Cordeiro in
Google Scholar
PubMed
Search for other papers by Tania Maria Ortiga-Carvalho in
Google Scholar
PubMed
Thyroid hormones (TH) are crucial for development, growth, differentiation, metabolism and thermogenesis. Skeletal muscle (SM) contractile function, myogenesis and bioenergetic metabolism are influenced by TH. These effects depend on the presence of the TH transporters MCT8 and MCT10 in the plasma membrane, the expression of TH receptors (THRA or THRB) and hormone availability, which is determined either by the activation of thyroxine (T4) into triiodothyronine (T3) by type 2 iodothyronine deiodinases (D2) or by the inactivation of T4 into reverse T3 by deiodinases type 3 (D3). SM relaxation and contraction rates depend on T3 regulation of myosin expression and energy supplied by substrate oxidation in the mitochondria. The balance between D2 and D3 expression determines TH intracellular levels and thus influences the proliferation and differentiation of satellite cells, indicating an important role of TH in muscle repair and myogenesis. During critical illness, changes in TH levels and in THR and deiodinase expression negatively affect SM function and repair. This review will discuss the influence of TH action on SM contraction, bioenergetics metabolism, myogenesis and repair in health and illness conditions.
Search for other papers by Débora Cristina de Moraes in
Google Scholar
PubMed
Search for other papers by Mario Vaisman in
Google Scholar
PubMed
Search for other papers by Flavia Lucia Conceição in
Google Scholar
PubMed
Search for other papers by Tânia Maria Ortiga-Carvalho in
Google Scholar
PubMed
Pituitary organogenesis is a highly complex and tightly regulated process that depends on several transcription factors (TFs), such as PROP1, PIT1 (POU1F1), HESX1, LHX3 and LHX4. Normal pituitary development requires the temporally and spatially organised expression of TFs and interactions between different TFs, DNA and TF co-activators. Mutations in these genes result in different combinations of hypopituitarism that can be associated with structural alterations of the central nervous system, causing the congenital form of panhypopituitarism. This review aims to elucidate the complex process of pituitary organogenesis, to clarify the role of the major TFs, and to compile the lessons learned from functional studies of TF mutations in panhypopituitarism patients and TF deletions or mutations in transgenic animals.
Search for other papers by Luana Lopes Souza in
Google Scholar
PubMed
Search for other papers by Aline Cordeiro in
Google Scholar
PubMed
Search for other papers by Lorraine Soares Oliveira in
Google Scholar
PubMed
Search for other papers by Gabriela Silva Monteiro de Paula in
Google Scholar
PubMed
Search for other papers by Larissa Costa Faustino in
Google Scholar
PubMed
Search for other papers by Tania Maria Ortiga-Carvalho in
Google Scholar
PubMed
Search for other papers by Karen Jesus Oliveira in
Google Scholar
PubMed
Search for other papers by Carmen Cabanelas Pazos-Moura in
Google Scholar
PubMed
n-3 polyunsaturated fatty acids (n-3 PUFA) from fish oil (FO) exert important lipid-lowering effects, an effect also ascribed to thyroid hormones (TH) and TH receptor β1 (TRβ1)-specific agonists. n-3 PUFA effects are mediated by nuclear receptors, such as peroxisome proliferator-activated receptors (PPAR) and others. In this study, we investigated a role for TH signaling in n-3 PUFA effects. Euthyroid and hypothyroid adult rats (methimazole-treated for 5 weeks) received FO or soybean oil (control) by oral administration for 3 weeks. In euthyroid rats, FO treatment reduced serum triglycerides and cholesterol, diminished body fat, and increased protein content of the animals. In addition, FO-treated rats exhibited higher liver expression of TRβ1 and mitochondrial α-glycerophosphate dehydrogenase (mGPD), at protein and mRNA levels, but no alteration of glutathione S-transferase or type 1 deiodinase. In hypothyroid condition, FO induced reduction in serum cholesterol and increase in body protein content, but lost the ability to reduce triglycerides and body fat, and to induce TRβ1 and mGDP expression. FO did not change PPARα liver abundance regardless of thyroid state; however, hypothyroidism led to a marked increase in PPARα liver content but did not alter TRβ1 or TRα expression. The data suggest that part of the effect of n-3 PUFA from FO on lipid metabolism is dependent on TH signaling in specific steps and together with the marked upregulation of PPARα in liver of hypothyroid rats suggest important in vivo consequences of the cross-talking between those fatty acids and TH pathways in liver metabolism.
Search for other papers by Aline Cordeiro in
Google Scholar
PubMed
Search for other papers by Luana Lopes de Souza in
Google Scholar
PubMed
Search for other papers by Lorraine Soares Oliveira in
Google Scholar
PubMed
Search for other papers by Larissa Costa Faustino in
Google Scholar
PubMed
Search for other papers by Letícia Aragão Santiago in
Google Scholar
PubMed
Search for other papers by Flavia Fonseca Bloise in
Google Scholar
PubMed
Search for other papers by Tania Maria Ortiga-Carvalho in
Google Scholar
PubMed
Search for other papers by Norma Aparecida dos Santos Almeida in
Google Scholar
PubMed
Search for other papers by Carmen Cabanelas Pazos-Moura in
Google Scholar
PubMed
Sirtuin 1 (SIRT1), a NAD+-dependent deacetylase, has been connected to beneficial effects elicited by calorie restriction. Physiological adaptation to starvation requires higher activity of SIRT1 and also the suppression of thyroid hormone (TH) action to achieve energy conservation. Here, we tested the hypothesis that those two events are correlated and that TH may be a regulator of SIRT1 expression. Forty-eight-hour fasting mice exhibited reduced serum TH and increased SIRT1 protein content in liver and brown adipose tissue (BAT), and physiological thyroxine replacement prevented or attenuated the increment of SIRT1 in liver and BAT of fasted mice. Hypothyroid mice exhibited increased liver SIRT1 protein, while hyperthyroid ones showed decreased SIRT1 in liver and BAT. In the liver, decreased protein is accompanied by reduced SIRT1 activity and no alteration in its mRNA. Hyperthyroid and hypothyroid mice exhibited increases and decreases in food intake and body weight gain respectively. Food-restricted hyperthyroid animals (pair-fed to euthyroid group) exhibited liver and BAT SIRT1 protein levels intermediary between euthyroid and hyperthyroid mice fed ad libitum. Mice with TH resistance at the liver presented increased hepatic SIRT1 protein and activity, with no alteration in Sirt1 mRNA. These results suggest that TH decreases SIRT1 protein, directly and indirectly, via food ingestion control and, in the liver, this reduction involves TRβ. The SIRT1 reduction induced by TH has important implication to integrated metabolic responses to fasting, as the increase in SIRT1 protein requires the fasting-associated suppression of TH serum levels.
